| Overview |
| bsm-61287r |
| ILK Recombinant Antibody |
| WB, IP, Flow-Cyt, ICC/IF |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human ILK |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 3611 |
| Q13418 |
| Cytoplasm, Cell membrane |
| ILK; DKFZp686F1765; P59; ILK1; Integrin linked protein kinas. |
| Integrin-linked kinases (ILKs) couple integrins and growth factors to downstream pathways involved in cell survival, cell cycle control, cell-cell adhesion and cell motility. ILK functions as a scaffold bridging the extracellular matrix (ECM) and growth factor receptors to the actin cytoskeleton through interactions with integrin, PINCH (which links ILK to the RTKs via Nck2), CH-ILKBP and affixin. |
| Application Dilution |
| WB |
1:300-5000 |
| IP |
1-2ug |
| Flow-Cyt |
1ug/Test |
| ICC/IF |
1:50-100 |